The correlation between diabetes mellitus and depression
DOI:
https://doi.org/10.12775/JEHS.2024.74.52086Keywords
diabetes mellitus and depression, dm and depression, treatment of depression in patients with dm, treatment od diabetes in patients with depression, physical activity in people with depression and diabetesAbstract
Depression is the most prevalent mental health condition. It’s estimated that nearly 5% of adults suffer from this disorder globally. Depression is marked by ongoing sadness and a loss of interest or pleasure in activities that were once enjoyable or fulfilling. It can also lead to disruptions in sleep and eating patterns. Common symptoms include fatigue and difficulty concentrating.
According to WHO diabetes is a chronic, metabolic disease characterized by elevated levels of blood glucose which leads to the damage of the heart, blood vessels, eyes, kidneys and nerves. Nowadays the occurrence of diabetes mellitus, obesity and depression is getting higher and higher. Both conditions stand as prominent health issues in today’s society. Recent pandemic, wars, problems of the current world can cause depression and anxiety disorders. The fast-paced nature of our lives, work-life balance issues, sedentary habits, and time constraints can lead to opting for fast food and neglecting a healthy diet. People with diabetes are more prone to experiencing depression. Moreover, a significant portion of cases remains underdiagnosed.
References
Bădescu SV, Tătaru C, Kobylinska L, Georgescu EL, Zahiu DM, Zăgrean AM, Zăgrean L. The association between Diabetes mellitus and Depression. J Med Life. 2016 Apr-Jun;9(2):120-5.
Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk A. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011;40:804–818. doi: 10.1093/ije/dyr029.
Folb N, Lund C, Fairall LR, Timmerman V, Levitt NS, Steyn K, Bachmann MO. Socioeconomic predictors and consequences of depression among primary care attenders with non-communicable diseases in the Western Cape, South Africa: cohort study within a randomised trial. BMC Public Health. 2015 Nov 30;15:1194. doi: 10.1186/s12889-015-2509-4.
Kyrou I, Tsigos C. Stress hormones: physiological stress and regulation of metabolism. Curr Opin Pharmacol. 2009 Dec;9(6):787-93. doi: 10.1016/j.coph.2009.08.007.
Moulton CD, Costafreda SG, Horton P, Ismail K, Fu CH. Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes. Brain Imaging Behav. 2015 Dec;9(4):651-62. doi: 10.1007/s11682-014-9348-2.
Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL, Lupien SJ, Roozendaal B, Seckl JR. Do corticosteroids damage the brain? J Neuroendocrinol. 2006 Jun;18(6):393-411. doi: 10.1111/j.1365-2826.2006.01429.x.
Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006 Jan;27(1):24-31. doi: 10.1016/j.it.2005.11.006.
Grey M, Whittemore R, Tamborlane W. Depression in type 1 diabetes in children: natural history and correlates. J Psychosom Res. 2002 Oct;53(4):907-11. doi: 10.1016/s0022-3999(02)00312-4.
Korczak DJ, Pereira S, Koulajian K, Matejcek A, Giacca A. Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link. Diabetologia. 2011 Oct;54(10):2483-93. doi: 10.1007/s00125-011-2240-3.
Hassan K, Loar R, Anderson BJ, Heptulla RA. The role of socioeconomic status, depression, quality of life, and glycemic control in type 1 diabetes mellitus. J Pediatr. 2006 Oct;149(4):526-31. doi: 10.1016/j.jpeds.2006.05.039.
Rush WA, Whitebird RR, Rush MR, et al. Depression in patients with diabetes: Does it impact clinical goal? J Am Board Fam Med. 2008;21(5):392–7. doi: 10.3122/jabfm.2008.05.070101.
Berge LI, Riise T. Comorbidity between Type 2 Diabetes and Depression in the Adult Population: Directions of the Association and Its Possible Pathophysiological Mechanisms. Int J Endocrinol. 2015;2015:164760. doi: 10.1155/2015/164760.
Rubin RR, Ma Y, Peyrot M, Marrero DG, Price DW, Barrett-Connor E, Knowler WC; Diabetes Prevention Program Research Group. Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study. Diabetes Care. 2010 Dec;33(12):2549-51. doi: 10.2337/dc10-1033.
McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf. 2006 Jan;5(1):157-68. doi: 10.1517/14740338.5.1.157.
McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf. 2006 Jan;5(1):157-68. doi: 10.1517/14740338.5.1.157.
Kim GM, Woo JM, Jung SY, Shin S, Song HJ, Park J, Ahn J. Positive association between serious psychiatric outcomes and complications of diabetes mellitus in patients with depressive disorders. Int J Psychiatry Med. 2015;50(2):131-46. doi: 10.1177/0091217415605024.
Meurs M, Roest AM, Wolffenbuttel BH, Stolk RP, de Jonge P, Rosmalen JG. Association of Depressive and Anxiety Disorders With Diagnosed Versus Undiagnosed Diabetes: An Epidemiological Study of 90,686 Participants. Psychosom Med. 2016 Feb-Mar;78(2):233-41. doi: 10.1097/PSY.0000000000000255.
Berge LI, Riise T. Comorbidity between Type 2 Diabetes and Depression in the Adult Population: Directions of the Association and Its Possible Pathophysiological Mechanisms. Int J Endocrinol. 2015;2015:164760. doi: 10.1155/2015/164760.
Oliveira RA, Tostes M, Queiroz VA, Rodacki M, Zajdenverg L. Insulin mediated improvement in glycemic control in elderly with type 2 diabetes mellitus can improve depressive symptoms and does not seem to impair health-related quality of life. Diabetol Metab Syndr. 2015 Jun 24;7:55. doi: 10.1186/s13098-015-0052-1.
van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ. Brain imaging in patients with diabetes: a systematic review. Diabetes Care. 2006 Nov;29(11):2539-48. doi: 10.2337/dc06-1637.
Gold SM, Dziobek I, Sweat V, Tirsi A, Rogers K, Bruehl H, Tsui W, Richardson S, Javier E, Convit A. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia. 2007 Apr;50(4):711-9. doi: 10.1007/s00125-007-0602-7.
Markowitz SM, Gonzalez JS, Wilkinson JL, Safren SA. A review of treating depression in diabetes: emerging findings. Psychosomatics. 2011 Jan-Feb;52(1):1-18. doi: 10.1016/j.psym.2010.11.007.
Gonzalez JS, Safren SA, Delahanty LM, Cagliero E, Wexler DJ, Meigs JB, Grant RW. Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes. Diabet Med. 2008 Sep;25(9):1102-7. doi: 10.1111/j.1464-5491.2008.02535.x.
Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet. 2004 May 15;363(9421):1589-97. doi: 10.1016/S0140-6736(04)16202-8.
Cochran J, Conn VS. Meta-analysis of quality of life outcomes following diabetes self-management training. Diabetes Educ. 2008 Sep-Oct;34(5):815-23. doi: 10.1177/0145721708323640.
MacGillivray S, Arroll B, Hatcher S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ. 2003 May 10;326(7397):1014. doi: 10.1136/bmj.326.7397.1014.
Sclar DA, Robinson LM, Skaer TL, Galin RS. Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990-1995. Clin Ther. 1998 Jul-Aug;20(4):871-84; 870. doi: 10.1016/s0149-2918(98)80148-3.
Goodnick PJ. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry. 2001 Mar;13(1):31-41. doi: 10.1023/a:1009012815127.
Thase ME, Haight BR, Richard N, Rockett CB, Mitton M, Modell JG, VanMeter S, Harriett AE, Wang Y. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry. 2005 Aug;66(8):974-81. doi: 10.4088/jcp.v66n0803.
Haddad PM, Sharma SG. Adverse effects of atypical antipsychotics : differential risk and clinical implications. CNS Drugs. 2007;21(11):911-36. doi: 10.2165/00023210-200721110-00004.
Detka, J., Głombik, K. Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression. Pharmacol. Rep 73, 1020–1032 (2021). https://doi.org/10.1007/s43440-021-00274-8
World Health Organization [Internet] Physical inactivity: A global public health problem. [cited 2011 Mar 21]. Available from: http://www.who.int/dietphysicalactivity/factsheet_inactivity/en/
Kim DJ. Effects of Physical Activity on Depression in Adults with Diabetes. Osong Public Health Res Perspect. 2018 Aug;9(4):143-149. doi: 10.24171/j.phrp.2018.9.4.02.
20. Camacho RC, Galassetti P, Davis SN, Wasserman DH. Glucoregulation during and after exercise in health and insulin-dependent diabetes. Exerc Sport Sci Rev. 2005 Jan;33(1):17-23.
Kim EH, Jung JO. The relationships among self-esteem, age-identify, and psychological happiness in rhythm exercise welfare program of elders. J Korean Soc Rhythm Exer. 2013;6(1):1-12.
Kim CW, Lee HW. Effects of an 8weeks walking exercise on blood lipid and HbA1c in obese old women. J Korean Sport Assoc. 2017;15(2):609–16.
Lee JJ, Bae JJ. Effects of long-term exercise training intervention on health fitness, blood pressure and blood glucose in elderly people. Kinesiology. 2010;12(2):55–65.
Geiker, N.R.W.; Astrup, A.; Hjorth, M.F.; Sjödin, A.; Pijls, L.; Markus, C.R. Does Stress Influence Sleep Patterns, Food Intake, Weight Gain, Abdominal Obesity and Weight Loss Interventions and Vice Versa? Obes. Rev. 2018, 19, 81–97.
Exploring the Interrelationships between Diabetes, Nutrition, Anxiety, and Depression: Implications for Treatment and Prevention Strategies, Raedeh Basiri , Blessing Seidu , Mark Rudich, DOI: 10.3390/nu15194226
Paans, N.P.G.; Gibson-Smith, D.; Bot, M.; van Strien, T.; Brouwer, I.A.; Visser, M.; Penninx, B.W.J.H. Depression and Eating Styles Are Independently Associated with Dietary Intake. Appetite 2019, 134, 103–110.
Sarlio-Lähteenkorva, S.; Lahelma, E.; Roos, E. Mental Health and Food Habits among Employed Women and Men. Appetite 2004, 42, 151–156.
Zheng, L.; Sun, J.; Yu, X.; Zhang, D. Ultra-Processed Food Is Positively Associated with Depressive Symptoms Among United States Adults. Front. Nutr. 2020, 7, 600449.
Sheikhi, A.; Siassi, F.; Djazayery, A.; Guilani, B.; Azadbakht, L. Plant and Animal Protein Intake and Its Association with Depression, Anxiety, and Stress among Iranian Women. BMC Public Health 2023, 23, 161.
32. Sadeghi, O.; Keshteli, A.H.; Afshar, H.; Esmaillzadeh, A.; Adibi, P. Adherence to Mediterranean Dietary Pattern Is Inversely Associated with Depression, Anxiety and Psychological Distress. Nutr. Neurosci. 2021, 24, 248–259.
Chen, L.; Liu, B.; Ren, L.; Du, H.; Fei, C.; Qian, C.; Li, B.; Zhang, R.; Liu, H.; Li, Z.; et al. High-Fiber Diet Ameliorates Gut Microbiota, Serum Metabolism and Emotional Mood in Type 2 Diabetes Patients. Front. Cell. Infect. Microbiol. 2023, 13, 1069954.
Sánchez-Villegas, A.; Cabrera-Suárez, B.; Molero, P.; González-Pinto, A.; Chiclana-Actis, C.; Cabrera, C.; Lahortiga-Ramos, F.; Florido-Rodríguez, M.; Vega-Pérez, P.; Vega-Pérez, R.; et al. Preventing the Recurrence of Depression with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil. The PREDI-DEP Trial: Study Protocol. BMC Psychiatry 2019, 19, 63
Mazaherioun, M.; Saedisomeolia, A.; Javanbakht, M.H.; Koohdani, F.; Zarei, M.; Ansari, S.; Khoshkhoo Bazargani, F.; Djalali, M. Long Chain N-3 Fatty Acids Improve Depression Syndrome in Type 2 Diabetes Mellitus. Iran J. Public Health 2018, 47, 575–583.
Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care. 2003 Oct;26(10):2822-8. doi: 10.2337/diacare.26.10.2822.
Twist K, Stahl D, Amiel SA, Thomas S, Winkley K, Ismail K. Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design. Psychosom Med. 2013 Oct;75(8):791-7. doi: 10.1097/PSY.0b013e3182a2b108.
Roy T, Lloyd CE, Pouwer F, Holt RI, Sartorius N. Screening tools used for measuring depression among people with Type 1 and Type 2 diabetes: a systematic review. Diabet Med. 2012 Feb;29(2):164-75. doi: 10.1111/j.1464-5491.2011.03401.x.
Kroenke K, Spitzer RL, Williams JB, Löwe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59. doi: 10.1016/j.genhosppsych.2010.03.006.
Petrak F, Baumeister H, Skinner TC, Brown A, Holt RIG. Depression and diabetes: treatment and health-care delivery. Lancet Diabetes Endocrinol. 2015 Jun;3(6):472-485. doi: 10.1016/S2213-8587(15)00045-5.
Park IB, Baik SH. Epidemiologic characteristics of diabetes mellitus in Korea: Current status of diabetic patients using Korean health insurance database. Kor Diabetes J. 2009;33(5):357–62. doi: 10.4093/kdj.2009.33.5.357.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Magdalena Madera, Sylwia Mazur, Agata Mazur, Aleksy Bizan, Emilia Nagórska, Krzysztof Marcinkowski, Karolina Strus, Aleksandra Kublińska, Roksana Zdunek, Natalia Dąbrowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 731
Number of citations: 0
